Provided by Tiger Fintech (Singapore) Pte. Ltd.

2Seventy Bio Inc

4.99
+0.01000.20%
Volume:287.06K
Turnover:1.43M
Market Cap:265.61M
PE:-4.55
High:4.99
Open:4.98
Low:4.98
Close:4.98
Loading ...

April 2025's Promising Penny Stock Highlights

Simply Wall St.
·
02 Apr

2seventy bio Q4 Loss Narrows, Revenue Falls

MT Newswires Live
·
26 Mar

2Seventy Bio Q4 Basic EPS USD -0.37

Reuters
·
26 Mar

2seventy bio Q4 2024 GAAP EPS $(0.37) Misses $(0.24) Estimate, Sales $2.926 Miss $12.293M Estimate

Benzinga
·
26 Mar

Press Release: 2seventy bio Reports Fourth Quarter and Full Year 2024 Financial Results

Dow Jones
·
26 Mar

2Seventy Bio Inc expected to post a loss of 26 cents a share - Earnings Preview

Reuters
·
14 Mar

2seventy bio Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
14 Mar

Sector Update: Health Care Stocks Lower in Late Afternoon Trading

MT Newswires Live
·
12 Mar

TSVT Up on Acquisition Agreement With BMY for $286 Million

Zacks
·
12 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney

Reuters
·
12 Mar

Crude Oil Gains 1%; Ciena Earnings Top Views

Benzinga
·
12 Mar

Deals of the day-Mergers and acquisitions

Reuters
·
11 Mar

2seventy bio Shares up 76% as Bristol Myers Squibb Acquires Co for About $286 Million

THOMSON REUTERS
·
11 Mar

2seventy bio (TSVT) was downgraded to a Hold Rating at Leerink Partners

TIPRANKS
·
11 Mar

2seventy bio Cut to Market Perform From Outperform by Leerink Partners

Dow Jones
·
11 Mar

Leerink Partners Downgrades 2seventy Bio to Market Perform From Outperform, Adjusts Price Target to $5 From $9

MT Newswires Live
·
11 Mar

Bristol Myers to Buy Collaborator 2Seventy Bio for $286 Mln

Investing.com
·
11 Mar

US Stocks Likely To Open Higher After Monday's Selloff: TSLA Stock Rebounds From Its Worst Fall In 5 Years After Trump Backs Musk, Analyst Says 'Pullbacks Are Normal'

Benzinga
·
11 Mar

2seventy Bio downgraded to Market Perform from Outperform at Leerink

TIPRANKS
·
11 Mar

2seventy Bio Shares Soar Premarket on Deal to be Acquired by Bristol Myers

Dow Jones
·
11 Mar